Recombinant Helicobacter pylori Acetyl-coenzyme A synthetase (acsA), partial

What is the biological function of Acetyl-coenzyme A synthetase (AcsA) in H. pylori metabolism?

Acetyl-coenzyme A synthetase (AcsA) in H. pylori, like in other bacteria, is responsible for the critical conversion of acetate to acetyl-CoA through an ATP-dependent reaction. This enzyme plays a central role in carbon metabolism by channeling acetate into the TCA cycle and fatty acid biosynthesis pathways.

In bacterial systems, including H. pylori, AcsA catalyzes a two-step reaction:

• Acetate + ATP → Acetyl-AMP + PPi

• Acetyl-AMP + CoA → Acetyl-CoA + AMP

This metabolic function is particularly important for H. pylori, which has a relatively limited metabolic capacity compared to other bacteria but needs to efficiently utilize available carbon sources in the harsh gastric environment .

How is AcsA activity regulated in bacteria, and does H. pylori employ similar regulatory mechanisms?

AcsA activity in many bacteria is regulated through posttranslational modification, specifically reversible lysine acetylation (RLA). In organisms like Bacillus subtilis, the acuABC operon encodes a protein acetyltransferase (AcuA) and a protein deacetylase (AcuC) that control AcsA activity .

The regulatory mechanism works as follows:

• AcuA transfers an acetyl group from acetyl-CoA to a conserved lysine residue in AcsA, inactivating the enzyme

• AcuC removes the acetyl group, reactivating AcsA

While this specific regulatory system hasn't been directly confirmed in H. pylori, genomic analysis suggests the presence of similar acetylation/deacetylation machinery. The importance of this regulation lies in preventing futile cycling, as uncontrolled AcsA activity can lead to cellular ATP depletion and energy crisis .

What expression systems are most effective for producing recombinant H. pylori AcsA?

For recombinant expression of H. pylori AcsA, Escherichia coli-based expression systems have proven most effective, particularly for biochemical and structural studies. Several factors must be considered when designing an expression system:

Expression host optimization:

• BL21(DE3) and its derivatives are common choices for H. pylori protein expression

• Codon optimization may be necessary due to H. pylori's AT-rich genome

• Lower expression temperatures (16-25°C) often yield better soluble protein

Vector selection considerations:

• pET vectors with T7 promoter systems provide high-level expression

• Addition of solubility tags (His, GST, MBP) can improve protein solubility

• Inclusion of protease cleavage sites allows tag removal for functional studies

Based on studies with other H. pylori proteins, expression protocols typically involve induction with 0.1-0.5 mM IPTG at mid-log phase, followed by overnight expression at lower temperatures .

What purification strategies yield the highest activity for recombinant H. pylori AcsA?

Purification of recombinant H. pylori AcsA requires careful consideration to maintain enzymatic activity. Based on protocols used for similar enzymes, the following purification strategy is recommended:

Step-by-step purification protocol:

• Cell lysis in buffer containing 50 mM HEPES (pH 7.5), 300 mM NaCl, 10% glycerol, and protease inhibitors

• Initial capture using affinity chromatography (Ni-NTA for His-tagged constructs)

• Intermediate purification using ion exchange chromatography

• Polishing step with size exclusion chromatography

• Storage in buffer containing reducing agent (TCEP or DTT) to maintain thiol groups

Table 1: Optimized Buffer Conditions for H. pylori AcsA Purification

Preserving activity often requires the addition of stabilizing agents like glycerol and reducing agents to prevent oxidation of catalytic cysteine residues .

How can the enzymatic activity of recombinant H. pylori AcsA be reliably measured?

Enzymatic activity of recombinant H. pylori AcsA can be measured using several complementary approaches:

Coupled enzymatic assays:
The most common method couples AcsA activity to the formation of NAD(P)H, which can be monitored spectrophotometrically at 340 nm. This involves:

• AcsA reaction: Acetate + ATP + CoA → Acetyl-CoA + AMP + PPi

• Coupling enzymes (malate dehydrogenase, citrate synthase) to link acetyl-CoA formation to NAD(P)H production

Direct product detection:

• HPLC analysis to quantify acetyl-CoA formation

• Radioactive assays using [14C]-labeled acetate to track conversion to [14C]-acetyl-CoA

• Mass spectrometry to detect and quantify reaction products

Pyrophosphate (PPi) release measurement:

• Colorimetric malachite green assay for released phosphate after pyrophosphatase treatment

• Enzyme-coupled assays that link PPi release to a colorimetric or fluorescent output

Typical activity assays are performed at 37°C in buffer containing 50 mM HEPES (pH 7.5), 1-5 mM MgCl₂, 1-2 mM ATP, 0.1-1 mM CoA, and varying concentrations of acetate (0.1-10 mM) .

What structural features of H. pylori AcsA are critical for its catalytic function?

While the specific crystal structure of H. pylori AcsA has not been reported in the provided search results, structural insights can be inferred from characterized AcsA enzymes from other organisms:

Key structural elements expected in H. pylori AcsA:

• N-terminal domain with an adenylate-forming fold responsible for ATP binding and acetate activation

• C-terminal domain containing the CoA binding pocket

• Conserved catalytic lysine residue that is susceptible to regulatory acetylation

• Domain rotation between the first reaction (formation of acetyl-AMP) and the second reaction (formation of acetyl-CoA)

The catalytic mechanism involves substantial conformational changes between the two half-reactions. The catalytic lysine residue (likely corresponding to Lys549 in B. subtilis AcsA) is critical not only for catalysis but also serves as the site for regulatory acetylation .

How does H. pylori AcsA potentially interact with other metabolic enzymes and pathways?

H. pylori AcsA likely functions as part of an integrated metabolic network, interacting with several other metabolic pathways:

Potential metabolic interactions:

• Acetate metabolism: AcsA likely works in concert with phosphotransacetylase and acetate kinase in acetate utilization

• TCA cycle: Acetyl-CoA produced by AcsA feeds into the TCA cycle for energy generation

• Fatty acid biosynthesis: Acetyl-CoA serves as a substrate for fatty acid synthesis

• Acetone metabolism: May interact with acetone carboxylase (AcxA/AcxB/AcxC), which has been shown to be important for H. pylori biofilm formation

Research suggests that disruption of acetone metabolism genes (acxA) in H. pylori results in significant biofilm defects, indicating interconnections between these metabolic pathways and bacterial persistence . The relationship between AcsA activity and biofilm formation represents an important area for future investigation.

What is the potential connection between H. pylori AcsA and virulence or pathogenesis?

While direct evidence linking H. pylori AcsA to virulence is limited in the provided search results, several potential connections can be hypothesized based on broader metabolic functions:

Potential roles in pathogenesis:

• Energy production: By providing acetyl-CoA for the TCA cycle, AcsA may support H. pylori survival in the nutrient-limited gastric environment

• Biofilm formation: Metabolic enzymes including those involved in acetate and acetone metabolism have been shown to contribute to H. pylori biofilm formation, which enhances bacterial persistence

• Host-pathogen interactions: Acetylation machinery in bacterial pathogens can influence host immune responses

The significance of metabolic enzymes in H. pylori pathogenesis is highlighted by findings that acetone metabolism genes, particularly acxA, are crucial for biofilm formation both on abiotic surfaces and gastric epithelial cells . This suggests metabolic enzymes like AcsA could represent underexplored virulence factors.

How might recombinant H. pylori AcsA be used as a potential drug target?

H. pylori AcsA represents a potential drug target based on several considerations:

Target validation rationale:

• Essential metabolism: As a key enzyme in acetate utilization, AcsA likely plays an important role in H. pylori survival and persistence

• Structural uniqueness: Bacterial AcsA enzymes have distinct structural features compared to human homologs

• Established precedent: Other metabolic enzymes have proven successful as antibiotic targets

Drug discovery approaches:

• Structure-based design targeting the ATP-binding pocket or acetate-binding site

• High-throughput screening of compound libraries against recombinant AcsA

• Fragment-based drug discovery to identify initial chemical scaffolds

Potential advantages as a target:

• Inhibiting AcsA could disrupt multiple downstream metabolic pathways

• May impact biofilm formation, reducing bacterial persistence

• Could potentially be combined with existing treatments for synergistic effects

What experimental techniques are most effective for studying protein-protein interactions involving H. pylori AcsA?

Several complementary techniques can be employed to study protein-protein interactions involving H. pylori AcsA:

In vitro techniques:

• GST-pull down assays: Have been successfully used to study interactions between H. pylori proteins, as demonstrated with MCAT and ACP interaction studies

• Surface plasmon resonance (SPR): Provides quantitative binding data including association/dissociation constants

• Isothermal titration calorimetry (ITC): Offers thermodynamic parameters of protein-protein interactions

Computational approaches:

• Molecular docking: Can predict potential interaction interfaces, as demonstrated in studies of H. pylori MCAT

• Protein-protein interaction network analysis: Helps identify potential interaction partners based on genomic context

In vivo techniques:

• Bacterial two-hybrid systems: Allow detection of protein interactions in a cellular context

• Co-immunoprecipitation: Captures physiologically relevant protein complexes

A multi-method approach is recommended, combining computational predictions with both in vitro and in vivo validation. For example, H. pylori MCAT-ACP interactions were successfully characterized using a combination of computational docking, GST-pull down assays, and surface plasmon resonance .

Is there a connection between H. pylori metabolism and its association with acute coronary syndrome (ACS)?

Recent research has established a significant association between H. pylori infection and acute coronary syndrome (ACS), though the specific role of bacterial metabolism in this relationship remains under investigation:

Evidence for H. pylori-ACS association:

• Meta-analysis of 44 studies (7,522 cases and 8,311 controls) showed H. pylori infection was associated with increased risk of ACS (OR = 2.03, 95% CI 1.66–2.47)

• The association was stronger in developing countries (OR = 2.58) compared to developed countries (OR = 1.69)

• A recent study in Chinese populations found an even stronger association (adjusted OR = 4.04, 95% CI: 1.76−9.25)

Potential metabolic mechanisms:

• Alteration of lipid metabolism in the host

• Promotion of inflammatory responses

• Potential role of bacterial metabolites acting as signaling molecules

H. pylori strains expressing cytotoxin-associated gene A (CagA) showed an even stronger association with ACS (OR = 2.39, 95% CI 1.21–4.74) , suggesting virulence factors work together with metabolic processes in disease pathogenesis.

The connection between specific metabolic enzymes like AcsA and ACS represents an important area for future research that could reveal new diagnostic markers or therapeutic targets .

What methodologies are most effective for site-directed mutagenesis studies of H. pylori AcsA?

Site-directed mutagenesis is a powerful approach for investigating structure-function relationships in H. pylori AcsA. Based on studies of related enzymes, the following methodologies are recommended:

Mutagenesis strategies:

• QuikChange approach: Particularly effective for single amino acid substitutions

• Gibson Assembly: Useful for introducing multiple mutations or larger sequence changes

• Golden Gate Assembly: Enables combinatorial mutagenesis to test multiple variants simultaneously

Key residues to target:

• The predicted catalytic lysine residue (based on alignment with other AcsA proteins)

• ATP-binding pocket residues

• Acetate-binding site residues

• Predicted regulatory acetylation sites

Functional assessment of mutants:

• Enzyme activity assays comparing wild-type and mutant proteins

• Thermal stability measurements to assess structural integrity

• Binding studies to determine effects on substrate affinity

Studies on AcsA from other bacteria have identified critical residues like Lys549 in B. subtilis as the site of regulatory acetylation . Similar approaches could be applied to H. pylori AcsA to elucidate its catalytic mechanism and regulation.